Mein Warenkorb

Human EGFR-coupled Magnetic Beads

User Reviews
Product Number/Spec
Price
Availability
Menge
MBE-K012-2mg
$1070.00
In Stock - Delivery in 2-3 business days
MBE-K012-10mg (5mg X 2)
$3350.00
In Stock - Delivery in 2 weeks
Gesamtanzahl Product Amount$ 0

Product Details

  • Items
    Size 2mg
    Size 10mg (5mg × 2)
    Particle size
    2 μm
    2 μm
    Physical appearance
    Powder mixture
    Powder mixture
    Binding Capacity
    >133 pmol (20 μg) antibody/mg beads
    >133 pmol (20 μg) antibody/mg beads
    Formulation
    PBS, pH7.4, with 10% Trehalose
    PBS, pH7.4, with 10% Trehalose
    Reconstitution
    2 mL sterile deionized water (1 mg beads/mL)
    5 mL sterile deionized water (1 mg beads/mL)
  • Product Description

    The biotinylated EGFR protein was conjugated to streptavidin magnetic beads. This pre-coupled magnetic bead product can capture the anti-EGFR antibody from various assay systems. The beads are in uniform size, narrow size distribution with large surface area and unique surface coating, which can help you get the best performance and highly reproducible results. This EGFR coupled magnetic beads will bring great convenience with minimum non-specific binding and developed protocols. This ready-to-use product could greatly save your time and hassle.

  • Application

    This product is intended for immunocapture, biopanning. This is a non-sterile product.

    * The Isotype control (Cat. No. SMB-B01) is sold separately.

  • Reconstitution

    See Certificate of Analysis (CoA) for detailed instruction.

  • Storage

    Upon receipt, please store the Beads at -20°C. The shelf life is 1 year at -20 °C.

    Please avoid more than 3 freeze-thaw cycles once reconstitution, immediate use after reconstitution is highly recommended.

  • Assay Principles

    Antibody Purification:
    1. Resuspend the lyophilized beads by adding the buffer of choice.
    2. Add analyte to the suspension, mix and incubate to enable specific binding of the beads and the target protein.
    3. Magnetize beads, remove supernatant, and wash unbound protein fractions to capture target protein-bound beads.
    4. Wash, magnetize the beads and collect purified target protein for use in downstream applications.

    The magnetic beads technology makes use of the easy and efficient collection of beads in magnetic field to facilitate antibody purification in a simple workflow of “bind-wash-elute”. In contrast to common separation techniques, this method does not require columns or centrifugation, and is therefore ideal in high-throughput applications.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Kunden haben auch angesehen

Data Display

  • Typical Data

     EGF R TYPICAL DATA

    Immobilized 35 μg EGFR protein to 1 mg Beads, can bind the Anti-EGFR Antibody (Cetuximab) with an EC50 of 0.737 μg/mL.

    Protocol

User Reviews
Publish Comment

FAQ

  • product

    Can lyophilized proteins remain stable during room-temperature shipping or temporary room-temperature exposure?

    In general, lyophilized proteins remain stable during room-temperature shipping or temporary exposure to room-temperature conditions.


    Many ACROBiosystems recombinant proteins are supplied in lyophilized (freeze-dried) form. The lyophilization process effectively removes moisture from the product, helping reduce degradation-related reactions and improve protein stability during transportation and storage.


    To evaluate the stability of lyophilized proteins under normal temperature conditions, ACROBiosystems conducted a stability study on 11 representative lyophilized protein products at 37°C. The study demonstrated that these proteins maintained good quality stability after storage at 37°C for approximately 20 days. Based on these validation results, temporary room-temperature exposure during shipping or handling is generally not expected to have a significant impact on product quality or downstream application performance.


    To ensure optimal long-term stability, products should be stored according to the storage conditions specified in the product Certificate of Analysis (COA) upon receipt.


    Supporting Document


Frontier Progress

 
Drug Development Progress
  • English Name:

    Epidermal growth factor receptor erbB1

  • Category:

  • Listed Drugs Count:

    39 Details

  • Clinical Drugs Count:

    206 Details

  • Highest R&D Stage:

    Approved

Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Kunden haben auch angesehen
  • Data Display
  • User Reviews
  • FAQ
Kontaktieren Sie uns